Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance, Inc.    WBA

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/25/2020 09/28/2020 09/29/2020 09/30/2020 10/01/2020 Date
35.43(c) 36.07(c) 35.38(c) 35.92(c) 35.87 Last
5 955 371 5 901 611 5 079 568 6 679 235 4 808 557 Volume
+1.14% +1.81% -1.91% +1.53% -0.14% Change
More quotes
Financials (USD)
Sales 2020 139 B - -
Net income 2020 641 M - -
Net Debt 2020 15 295 M - -
P/E ratio 2020 49,9x
Yield 2020 5,19%
Sales 2021 143 B - -
Net income 2021 3 509 M - -
Net Debt 2021 13 317 M - -
P/E ratio 2021 8,90x
Yield 2021 5,30%
Capitalization 31 126 M 31 126 M -
EV / Sales 2020 0,33x
EV / Sales 2021 0,31x
Nbr of Employees 287 000
Free-Float 61,4%
More Financials
Company
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (83.4%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and International (9.9%). At the end of August 2019, the activity is ensured through 13,882 outlets (including 9,277 in the United... 
More about the company
Notations Surperformance© of Walgreens Boots Alliance, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about WALGREENS BOOTS ALLIANCE, INC.
09/29Lewis checks out at Britain's Tesco, leaving challenges for new CEO
RE
09/28WALGREENS BOOTS ALLIANCE : Schedules Fourth Quarter and Fiscal 2020 Earnings Ann..
BU
09/25Some 3,500 U.S. companies sue over Trump-imposed Chinese tariffs
RE
09/25Some 3,500 U.S. companies sue over Trump-imposed Chinese tariffs
RE
09/18WALGREENS BOOTS ALLIANCE : Launches Test & Protect Program to Aid Businesses' CO..
AQ
09/18Five leading health care companies lost over $65 billion in market cap YTD
AQ
09/17WALGREENS BOOTS ALLIANCE, INC. : Triggering Events That Accelerate or Increase a..
AQ
09/17WALGREENS : Launches Walgreens : Test & Protect Program™ to Aid Businesses..
BU
09/17WALGREENS BOOTS ALLIANCE : Releases Global Diversity & Inclusion Report and Expa..
BU
09/17WALGREENS BOOTS ALLIANCE : The Boulder Group Arranges Sale of Single Tenant Net ..
AQ
09/15WALGREENS BOOTS ALLIANCE : Find Care receives high honors from Fierce Healthcare..
AQ
09/11Some Large Employers Reject Trump's Payroll-Tax Deferral Plan -- Update
DJ
09/07WALGREENS BOOTS ALLIANCE : Tesco's Booker boss follows CEO and finance chief in ..
RE
09/03More than 10% of British shops vacant, survey shows
RE
09/01Correction to Coupon-Clipping Article (Aug. 29)
DJ
More news
News in other languages on WALGREENS BOOTS ALLIANCE, INC.
08/31Amazon testet bald Lieferungen per Drohne in den USA
08/31Amazon va accélérer ses tests de livraison par drone
07/27Aktien New York Schluss: Robuster Wochenstart - Techwerte ziehen an
07/27Aktien New York: Dow zeigt sich robust - Techwerte ziehen wieder an
07/27WDH AKTIEN NEW YORK : Dow startet robust - Techwerte ziehen wieder an (AF)
More news
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 41,25 $
Last Close Price 35,92 $
Spread / Highest target 33,6%
Spread / Average Target 14,8%
Spread / Lowest Target 3,01%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
John T. Standley President
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
Sector and Competitors